Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy

Cancer Treatment Reviews
Xiangjiao MengJinming Yu

Abstract

Checkpoint blockades turn on a new paradigm shift in immunotherapy for cancer. Remarkable clinical efficacy, durable response and low toxicity of programmed death 1 (PD-1)/programmed death ligand-1 (PD-L1) checkpoint blockades have been observed in various malignancies. However, a lot of cancer patients failed to respond to the PD-1/PD-L1 checkpoint blockades. It is crucial to identify a biomarker to predict the response to checkpoint blockades. The overexpression of PD-L1 is an important and widely-explored predictive biomarker for the response to PD-1/PD-L1 antibodies. However PD-L1 staining cannot be used to accurately select patients for PD-1/PD-L1 pathway blockade due to the low prediction accuracy and dynamic changes. Tumor-infiltrating immune cells and molecules in the tumor microenvironment, or along with PD-L1 expression, may be important in predicting clinical benefits of PD-1/PD-L1 checkpoint blockades. Gene analysis has proven to be new approach for judging the potential clinical benefit of immune checkpoint inhibitors, such as mutational landscape and mismatch-repair deficiency. Further preclinical and clinical studies are necessary to carry out before its application in clinical practice. Challenges should be over...Continue Reading

References

Sep 13, 2001·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·S KaptainB Chen
Feb 17, 2007·Nature Immunology·Arlene H SharpeGordon J Freeman
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jun 5, 2012·The New England Journal of Medicine·Julie R BrahmerJon M Wigginton
Sep 18, 2012·Cell·Ramaswamy GovindanRichard K Wilson
Jun 4, 2013·The New England Journal of Medicine·Omid HamidAntoni Ribas
Jun 4, 2013·The New England Journal of Medicine·Jedd D WolchokMario Sznol
Aug 30, 2013·Science Translational Medicine·Stefani SprangerThomas F Gajewski
Sep 12, 2013·Nature Reviews. Genetics·Ian R WatsonLynda Chin
Sep 21, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mario Sznol, Lieping Chen
Oct 23, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey S WeberY Ann Chen
Feb 20, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ching-Yao YangPan-Chyr Yang
Mar 4, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J GoldsteinM J Overman
Apr 9, 2014·Cancer Immunology, Immunotherapy : CII·George C PrendergastAlexander J Muller
Apr 10, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Janis M TaubeRobert A Anders
Nov 11, 2014·Anti-cancer Agents in Medicinal Chemistry·Sara PilottoEmilio Bria
Nov 14, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Zoran GatalicaOmid Hamid
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertPaolo A Ascierto
Nov 20, 2014·The New England Journal of Medicine·Alexandra SnyderTimothy A Chan
Nov 20, 2014·The New England Journal of Medicine·Vassiliki A Boussiotis
Nov 28, 2014·Nature·Matthew M GubinRobert D Schreiber
Dec 3, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerHans J Hammers
Feb 16, 2015·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·A WangG T Liu
Feb 20, 2015·Molecular Cancer Therapeutics·Sandip Pravin Patel, Razelle Kurzrock
Apr 10, 2015·British Journal of Cancer·B Homet Moreno, A Ribas
Apr 22, 2015·The New England Journal of Medicine·Caroline RobertUNKNOWN KEYNOTE-006 investigators
Apr 22, 2015·The New England Journal of Medicine·Edward B GaronUNKNOWN KEYNOTE-001 Investigators
May 28, 2015·Cancer Immunology Research·Marcella CalleaSabina Signoretti
May 28, 2015·Cancer Immunology Research·Eliezer M Van AllenDavid A Barbie
Jun 2, 2015·The New England Journal of Medicine·Dung T LeLuis A Diaz
Jun 2, 2015·The New England Journal of Medicine·Julie BrahmerDavid R Spigel

❮ Previous
Next ❯

Citations

Jan 23, 2016·Expert Review of Vaccines·Constantin N Baxevanis, Sonia A Perez
Apr 22, 2016·Respirology : Official Journal of the Asian Pacific Society of Respirology·Antonius StevenBruce W Robinson
Jun 18, 2016·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Marie KostineJudith V M G Bovée
May 3, 2016·Human Vaccines & Immunotherapeutics·Arun RajanJames L Gulley
Aug 23, 2016·Expert Opinion on Drug Metabolism & Toxicology·Ashley C Y Wong, Brigette Ma
Jan 6, 2017·International Journal of Molecular Sciences·Angela TossLaura Cortesi
Jan 6, 2017·Current Medical Research and Opinion·Burak BilginBülent Yalçın
May 11, 2017·Pediatric Blood & Cancer·Navin PintoErin R Rudzinski
Jan 26, 2017·Veterinary and Comparative Oncology·J CoyS Dow
Feb 2, 2017·Journal of Biomedical Science·Chiou-Feng LinTsung-Ting Tsai
Nov 10, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Chaitanya Divgi
Nov 28, 2017·Angewandte Chemie·Markella KonstantinidouAlexander Dömling
Nov 17, 2017·Biomaterials Science·Wooram ParkDong-Hyun Kim
Jun 2, 2018·Journal of Cellular and Molecular Medicine·Ying DaiBo Zhu
Nov 15, 2017·Future Oncology·Zineb HamilouYohann Loriot
Jul 13, 2018·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Clement Chung
Apr 27, 2018·International Journal of Cancer. Journal International Du Cancer·Masahiro ShibataMohammad Obaidul Hoque
Aug 11, 2018·Cancer Investigation·Jian L CampianStuart A Grossman
Sep 22, 2017·Endocrine-related Cancer·Maria Domenica Castellone, Rosa Marina Melillo
Nov 21, 2018·The Journal of Clinical Investigation·Dhiraj KumarSridhar Nimmagadda
Jan 19, 2018·Molecular Cancer·Su Yin LimHelen Rizos
Mar 21, 2019·Liver International : Official Journal of the International Association for the Study of the Liver·Jorge AdevaJuan W Valle
Dec 28, 2017·Nature Reviews. Genetics·Marcin Cieślik, Arul M Chinnaiyan
Aug 31, 2019·Expert Review of Molecular Diagnostics·Ernest Y Lee, Rajan P Kulkarni
Sep 20, 2019·Cancer Immunology, Immunotherapy : CII·Danyang SunYi Hu
Nov 6, 2018·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·X NiJ Suo
Jun 2, 2016·American Society of Clinical Oncology Educational Book·Kristen R SpencerJanice M Mehnert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Related Papers

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Sukhmani K PaddaHeather A Wakelee
Biomarkers in Cancer
Peilin Zheng, Zhiguang Zhou
© 2022 Meta ULC. All rights reserved